Is Echo IQ Limited a good investment? Echo IQ Limited (EIQ.AX) is currently trading at 1.65 AUD. Market analysts have a consensus price target of 1.69 AUD. This suggests a potential upside from current levels.
Earnings Schedule: Echo IQ Limited is expected to release its next earnings report on Aug. 27, 2026. The market consensus estimate for Forward EPS is -0.01.
No, it does not currently pay a dividend.
Echo IQ Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 27, 2026. The company currently has a trailing EPS of -0.03.
Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company has a research collaboration with Mayo Clinic to evaluate echo IQ's proprietary artificial intelligence platform for cardiac risk stratification in oncology patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is headquartered in Sydney, Australia.
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 13, 2019 | 0.100000 |
| Aug. 12, 2019 | 0.100000 |
| Dec. 9, 2015 | 1.060000 |
Community Discussion